Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1431]

AACR 2013: Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

AACR 2013: Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

Functional characteristics of antitumour T cells change with increasing time after therapeutic transfer

Functional characteristics of antitumour T cells change with increasing time after therapeutic transfer

Medical Education Workshop on Molecular Targeted Therapy of Cancer

Medical Education Workshop on Molecular Targeted Therapy of Cancer

BRAF inhibitor treatment causes melanoma cells to shift how they produce energy

BRAF inhibitor treatment causes melanoma cells to shift how they produce energy

Aspirin may lower melanoma risk

Aspirin may lower melanoma risk

Peptide-based cancer vaccine efficacy can be affected by formulation

Peptide-based cancer vaccine efficacy can be affected by formulation

First evidence that obesity gene is risk factor for melanoma

First evidence that obesity gene is risk factor for melanoma

Gene found in some melanoma linked to worse outcomes

Gene found in some melanoma linked to worse outcomes

Two drugs better one to treat most deadly skin cancer

Two drugs better one to treat most deadly skin cancer

Milestone of cancer research: Arresting cancers rather than killing them

Milestone of cancer research: Arresting cancers rather than killing them

More from ecancer